# Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke

> **NCT06242145** · PHASE3 · COMPLETED · sponsor: **Kafrelsheikh University** · enrollment: 580 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Clopidogrel tablet
- **DRUG:** Cilostazol 100 MG

## Key facts

- **NCT ID:** NCT06242145
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 580 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06242145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06242145, "Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06242145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*